Our Innovations

July 12, 2021
Anticancer Modes of Action

One of the IBAL modes of action targets cancer cells by apoptosis. Clinical studies on several […]

Read More
July 11, 2021
Preclinical Anticancer Efficacy Studies on IBAL Formulations

Preliminary Evaluation Of ION-ZC1 As A Potential Anticancer Agent In Vitro Completed in 2018 by Brooklyn […]

Read More
May 11, 2021
Cancer Rates Are on the Rise Globally

Cancer rates could further increase by 50% in the year 2020 This is according to the […]

Read More




Copyright © 2024 All Rights Reserved ionic Alliance Group, Inc.